Susquehanna Advisors Group Inc. Invests $26.93 Million in Semler Scientific, Inc. (NASDAQ:SMLR)

Susquehanna Advisors Group Inc. acquired a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 498,675 shares of the company's stock, valued at approximately $26,928,000. Semler Scientific accounts for 0.8% of Susquehanna Advisors Group Inc.'s holdings, making the stock its 20th biggest holding. Susquehanna Advisors Group Inc. owned 5.38% of Semler Scientific as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Stifel Financial Corp boosted its position in Semler Scientific by 107.9% during the 4th quarter. Stifel Financial Corp now owns 52,141 shares of the company's stock worth $2,816,000 after acquiring an additional 27,062 shares during the last quarter. MetLife Investment Management LLC acquired a new stake in Semler Scientific in the 4th quarter valued at $163,000. Capital International Investors bought a new stake in Semler Scientific during the 4th quarter worth about $30,813,000. NewEdge Advisors LLC boosted its stake in shares of Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock worth $40,000 after buying an additional 557 shares during the last quarter. Finally, EAM Investors LLC bought a new position in shares of Semler Scientific in the 4th quarter valued at about $805,000. 49.37% of the stock is owned by institutional investors and hedge funds.

Semler Scientific Stock Performance

Shares of Semler Scientific stock traded up $0.16 on Thursday, reaching $34.44. 142,805 shares of the stock were exchanged, compared to its average volume of 402,823. The firm's 50 day moving average is $37.39 and its 200-day moving average is $45.88. The firm has a market cap of $330.52 million, a PE ratio of 7.01 and a beta of 1.29. Semler Scientific, Inc. has a one year low of $20.88 and a one year high of $81.56.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping analysts' consensus estimates of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The company had revenue of $12.41 million for the quarter.

Analysts Set New Price Targets

Separately, Lake Street Capital upped their price objective on Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a research note on Friday, January 24th.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.